Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine TherapyMAHFOUZ, Reda Z; JANKOWSKA, Ania; ENGELKE, Kory J et al.Clinical cancer research (Print). 2013, Vol 19, Num 4, pp 938-948, issn 1078-0432, 11 p.Article

A Phase 2 Trial of Combination Therapy With Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients With Overlap Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) or Primary Myelofibrosis (PMF)BEJANYAN, Nelli; TIU, Ramon V; SEKERES, Mikkael A et al.Cancer. 2012, Vol 118, Num 16, pp 3968-3976, issn 0008-543X, 9 p.Article